{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:03:43Z","timestamp":1763017423645},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T00:00:00Z","timestamp":1404691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T00:00:00Z","timestamp":1404691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1038\/bmt.2014.140","type":"journal-article","created":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T14:58:17Z","timestamp":1404745097000},"page":"1193-1197","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Palifermin reduces infection rate and hyperfibrinogenemia in patients treated with high-dose chemotherapy based on beam or BU-thiothepa"],"prefix":"10.1038","volume":"49","author":[{"given":"G","family":"Milone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Leotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Cupri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A L","family":"Fauci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Spina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Berritta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Tripepi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,7]]},"reference":[{"key":"BFbmt2014140_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s15010-007-6350-2","volume":"35","author":"L Gil","year":"2007","unstructured":"Gil L, Styczynski G, Komarnicki M . Infectious complication in 314 patients after high dose therapy and autologous hematopoietic stem cell transplantation: risk factor analysis and outcome. Infection 2007; 35: 421\u2013427.","journal-title":"Infection"},{"key":"BFbmt2014140_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/sj.bmt.1700621","volume":"19","author":"K Kolbe","year":"1997","unstructured":"Kolbe K, Domkin D, Hg Derigs, Bhakdi S, Huber C, Aulitzky WE . Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19: 143\u2013147.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014140_CR3","first-page":"265","volume":"18","author":"SB Mossad","year":"1996","unstructured":"Mossad SB, Longworth D, Goormastic M, Serkey JM, Keys TF, Bolwell BJ . Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant 1996; 18: 265\u2013271.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014140_CR4","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1056\/NEJMoa040125","volume":"351","author":"R Spielberger","year":"2004","unstructured":"Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T et al. Palifermin for oral mucositis afterintensive therapy for hematologic cancers. New Engl J Med 2004; 351: 2590\u20132598.","journal-title":"New Engl J Med"},{"key":"BFbmt2014140_CR5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/bmt.2008.168","volume":"42","author":"P Tsirigotis","year":"2008","unstructured":"Tsirigotis P, Triantafyllou K, Girkas K, Giannopoulou V, Ioannidou E, Chondropoulos S et al. Keratinocyte growth factor is effective in theprevention of intestinal mucositis in patients with hematological malignanciestreated with high-dose chemotherapy and autologous hematopoietic SCT: a video-capsule endoscopy study. Bone Marrow Transplant 2008; 42: 337\u2013343.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014140_CR6","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/sj.bmt.1705846","volume":"40","author":"B Nasilowska-Adamska","year":"2007","unstructured":"Nasilowska-Adamska B, Rzepecki P, Manko J, Czyz A, Markiewicz M, Federowicz I et al. The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant. Bone Marrow Transplant 2007; 40: 983\u2013988.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014140_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00520-006-0105-y","volume":"15","author":"P Horsley","year":"2007","unstructured":"Horsley P, Bauer JD, Mazkowiack R, Gardner R, Bashford J . Palifermin improves severe mucositis, swallowing problems, nutrition impact symptoms, and length of stay in patients undergoing hematopoietic stem cell transplantation. Support Care Cancer 2007; 15: 105\u2013109.","journal-title":"Support Care Cancer"},{"key":"BFbmt2014140_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/bmt.2008.157","volume":"42","author":"S Langner","year":"2008","unstructured":"Langner S, Staber P, Schub N, Gramatzki M, Grothe W, Behre G et al. Palifermin reduces incidence and severity oforal mucositis in allogeneic stem-cell transplant recipients. Bone Marrow Transplant 2008; 42: 275\u2013279.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014140_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/bmt.2013.118","volume":"49","author":"AH Herbers","year":"2014","unstructured":"Herbers AH, van der Velden WJ, de Haan AF, Donnelly JP, Blijlevens NM . Impact of palifermin on intestinal mucositis of HSCT recipients after BEAM. Bone Marrow Transplant 2014; 49: 8\u201310.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014140_CR10","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/bmt.2012.257","volume":"48","author":"N Blijlevens","year":"2013","unstructured":"Blijlevens N, de Ch\u00e2teau M, Krivan G, Rabitsch W, Szomor A, Pytlik R et al. In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden. Bone Marrow Transplant 2013; 48: 966\u2013971.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014140_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4081\/dcth.2013.21","volume":"2","author":"G Milone","year":"2013","unstructured":"Milone G, Leotta S, Pinto V, Avola G, Camuglia MG, Tripepi G . Palifermin in high dose chemotherapy and autologous stem cell transplantation reduces infection rate. Drugs Cell Ther Hematol 2013; 2: 133\u2013146.","journal-title":"Drugs Cell Ther Hematol"},{"key":"BFbmt2014140_CR12","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912\u20132919.","journal-title":"Blood"},{"key":"BFbmt2014140_CR13","first-page":"409","volume":"9","author":"JP Donnelly","year":"1992","unstructured":"Donnelly JP, Muus P, Schattenberg A, De Witte T, Horrevorts A, De Pauw BE . A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients. Bone Marrow Transplant 1992; 9: 409\u2013413.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014140_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1046\/j.1365-2141.2000.02202.x","volume":"110","author":"AM Wardley","year":"2000","unstructured":"Wardley AM, Jayson GC, Swindell R, Morgenstern GR, Chang J, Bloor R et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol 2000; 110: 292\u2013299.","journal-title":"Br J Haematol"},{"key":"BFbmt2014140_CR15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1538-7836.2008.02895.x","volume":"6","author":"G Lissalde-Lavigne","year":"2008","unstructured":"Lissalde-Lavigne G, Combescure C, Muller L, Bengler C, Raillard A, Lefrant JY et al. Simple coagulation tests improve survival prediction in patients with septic shock. J Thromb Haemost 2008; 6: 645\u2013653.","journal-title":"J Thromb Haemost"},{"key":"BFbmt2014140_CR16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.12659\/AOT.883965","volume":"18","author":"I Wyle\u017co\u0142","year":"2013","unstructured":"Wyle\u017co\u0142 I, Snarski E, Markiewicz M, Kyrcz-Krzemie\u0144 S, J\u0119drzejczak WW, Walewski J . Comparison of benefits of early, delayed, and no administration of G-CSF after autologous peripheral blood stem cell transplantation in lymphoma patients. Ann Transplant 2013; 18: 336\u2013341.","journal-title":"Ann Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2014140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2014140","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2014140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T17:15:24Z","timestamp":1648055724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2014140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,7]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["BFbmt2014140"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2014.140","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,7]]},"assertion":[{"value":"4 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}